Identification of noncytotoxic and IL-10-producing CD8+AT2R + T cell population in response to ischemic heart injury

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6286-6293

  Curato, Caterina ^a   Slavic, Svetlana ^a   Dong, Jun ^b,c   Skorska, Anna ^a,d   Altarche Xifró, Wassim ^a,d   Miteva, Kapka ^a   Kaschina, Elena ^a   Thiel, Andreas ^b,c   Imboden, Hans ^e   Wang, Jianan ^f   Steckelings, Ulrike ^a   Steinhoff, Gustav ^d   Unger, Thomas ^a   Li, Jun ^a,d  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c German Rheumatism Research Centre   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; INTERLEUKIN-10; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS;

EID: 78650658230     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903681     Document Type: Article

References (21)

1. Maisel, A., D. Cesario, S. Baird, J. Rehman, P. Haghighi, and S. Carter. 1998. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ. Res. 82:458-463.
2. Varda-Bloom, N., J. Leor, D. G. Ohad, Y. Hasin, M. Amar, R. Fixler, A. Battler, M. Eldar, and D. Hasin. 2000. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J. Mol. Cell. Cardiol. 32:2141-2149.
3. de Scheerder, I. K., M. L. de Buyzere, J. R. Delanghe, D. L. Clement, and R. J. Wieme. 1989. Anti-myosin humoral immune response following cardiac injury. Autoimmunity 4:51-58.
4. Wu, L., M. Iwai, H. Nakagami, Z. Li, R. Chen, J. Suzuki, M. Akishita, M. de Gasparo, and M. Horiuchi. 2001. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104:2716-2721.
5. Kaschina, E., A. Grzesiak, J. Li, A. Foryst-Ludwig, M. Timm, F. Rompe, M. Sommerfeld, U. R. Kemnitz, C. Curato, P. Namsolleck, et al. 2008. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118:2523-2532.
6. de Gasparo, M., K. J. Catt, T. Inagami, J. W. Wright, and T. Unger. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52:415-472.
7. Matsumoto, T., R. Ozono, T. Oshima, H. Matsuura, T. Sueda, G. Kajiyama, and M. Kambe. 2000. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc. Res. 46:73-81.
8. Altarche-Xifró, W., C. Curato, E. Kaschina, A. Grzesiak, S. Slavic, J. Dong, K. Kappert, M. Steckelings, H. Imboden, T. Unger, and J. Li. 2009. Cardiac c-kit+ AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells 27:2488-2497.
9. Schieffer, B., C. Bünte, J. Witte, K. Hoeper, R. H. Böger, E. Schwedhelm, and H. Drexler. 2004. Comparative effects of AT1-antagonism and angiotensinconverting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J. Am. Coll. Cardiol. 44:362-368.
10. Adachi, Y., Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, M. Nakanishi, Y. Nakagawa, K. Tanimoto, et al. 2003. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 107:2406-2408.
11. Jurewicz, M., D. H. McDermott, J. M. Sechler, K. Tinckam, A. Takakura, C. B. Carpenter, E. Milford, and R. Abdi. 2007. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J. Am. Soc. Nephrol. 18:1093-1102.
12. Brinckmann, M., E. Kaschina, W. Altarche-Xifró, C. Curato, M. Timm, A. Grzesiak, J. Dong, K. Kappert, U. Kintscher, T. Unger, and J. Li. 2009. Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells. J. Mol. Cell. Cardiol. 47:66-75.
13. Ytrehus, K., Y. Liu, A. Tsuchida, T. Miura, G. S. Liu, X. M. Yang, D. Herbert, M. V. Cohen, and J. M. Downey. 1994. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol. 267: H2383-H2390.
14. Gilliet, M., and Y.-J. Liu. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:695-704.
15. Xystrakis, E., A. S. Dejean, I. Bernard, P. Druet, R. Liblau, D. Gonzalez-Dunia, and A. Saoudi. 2004. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104:3294-3301.
16. Busche, S., S. Gallinat, R. M. Bohle, A. Reinecke, J. Seebeck, F. Franke, L. Fink, M. Zhu, C. Sumners, and T. Unger. 2000. Expression of angiotensin AT (1) and AT (2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am. J. Pathol. 157:605-611.
17. Li, J., J. Culman, H. Hörtnagl, Y. Zhao, N. Gerova, M. Timm, A. Blume, M. Zimmermann, K. Seidel, U. Dirnagl, and T. Unger. 2005. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19:617-619.
18. Tsutamoto, T., A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, and M. Kinoshita. 2000. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J. Am. Coll. Cardiol. 35:714-721.
19. Frangogiannis, N. G., L. H. Mendoza, M. L. Lindsey, C. M. Ballantyne, L. H. Michael, C. W. Smith, and M. L. Entman. 2000. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J. Immunol. 165:2798-2808.
20. Dong, J., C. Ivascu, H. D. Chang, P. Wu, R. Angeli, L. Maggi, F. Eckhardt, L. Tykocinski, C. Haefliger, B. Möwes, et al. 2007. IL-10 is excluded from the functional cytokine memory of human CD4+ memory T lymphocytes. J. Immunol. 179:2389-2396.
21. Accapezzato, D., V. Francavilla, M. Paroli, M. Casciaro, L. V. Chircu, A. Cividini, S. Abrignani, M. U. Mondelli, and V. Barnaba. 2004. Hepatic expansion of a virus-specific regulatory CD8 (+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113:963-972.